Saturday, 23 October 2021

 

 

LATEST NEWS Establishment of 400 Nagarvans in Country on anvil : Ashwini Kumar Choubey Lt Governor pays homage to brave soldiers, civilians martyred in the October 1947 terror attack by Pakistan army Chairperson FSSAI reviews functioning of J&K Drug & Food Control Department DC Shopian chairs meeting on implementation of Forest Rights Act DC Shopian reviews Winter preparedness in the district DDC Anantnag reviews pace/ progress of ongoing work projects by various departments DG Horticulture conducts extensive visit of Pulwama Union MoS for W&CD and AYUSH presides over one–day capacity building program for potential farmers at GUMC&H Ganderbal Chief Secretary approves implementation of "District Good Governance Index" in districts of J&K Dr Arun Kumar Mehta inaugurates Mining Department’s Web Portal Advisor Farooq Ahmad Khan attends closing ceremony of District Badminton Championship at GDC Pampore Awareness programme on World Iodine Deficiency Day held in Doda AYUSH Kishtwar celebrates ‘Magic Week’ under Azadi Ka Amrut Mahotsav Bulletin on COVID-19 : 108 fresh cases reported, 326195 recovered so far across J&K Doda Police organises debate competition on “Role of Police in Nation Building’ Samantha Ruth Prabhu could simply seek apology rather than filing defamation cases Deepika Padukone, Ranveer Singh likely to bid for new IPL team: Report I am hoping that 5-0 record in T20 World Cup will become 5-1 : Younis Khan 'Molnupiravir may be a game changer in fight against Covid-19' Facebook to pay French publishers for reusing their content 95% people do not need BJP : Akhilesh Yadav

 

Ibuprofen safe, doesn't raise Covid death risk : Study

Coronavirus, COVID 19, Novel Coronavirus, Covaxin, Covishield, Covid-19 Vaccine, COVID-19 Vaccination, COVID Vaccination, Coronavirus Vaccine, Oxygen, #OxygenCylinders, #oxygen, Oxygen Cylinders, SARS-CoV-2, Health, Study, London, Research, Researchers, World News, Non-steroidal anti-inflammatory drugs, NSAIDs, Ibuprofen

Web Admin

Web Admin

5 Dariya News

London , 09 May 2021

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, is safe and does not lead to higher rates of death or severe disease in patients hospitalised with Covid-19, according to a new observational study of more than 72,000 people in the UK.NSAIDs are common treatments for acute pain and rheumatological diseases such as rheumatoid arthritis and osteoarthrosis.Early in the pandemic, there was debate on whether the use of such drugs increased the severity of Covid-19, which led to urgent calls for investigations between NSAIDs and Covid-19.But, the study, led by ISARIC CCP-UK (International Severe Acute Respiratory and emerging Infection Consortium Clinical Characterisation Protocol United Kingdom), provides clear evidence that the continued use of NSAIDs in patients with Covid-19 is safe.The findings are published in The Lancet Rheumatology journal.Around a third of patients (30.4 per cent) who had taken NSAIDs prior to hospital admission for Covid-19 died, a rate which was similar (31.3 per cent) in patients who had not taken NSAIDs. 

In patients with rheumatological disease, the use of NSAIDs did not increase mortality.Further, those who took NSAIDs were not more likely to be admitted to critical care, need invasive or non-invasive ventilation, or require oxygen, the researchers found."We now have clear evidence that NSAIDs are safe to use in patients with Covid-19, which should provide reassurance to both clinicians and patients that they can continue to be used in the same way as before the pandemic began," said lead author Ewen Harrison, from the University of Edinburgh.For the study, the team collected data on the medication patients had been prescribed, were currently taking, or had taken within 14 days prior to being admitted to hospital, as well as demographic information, and medical history. Of the 72,179 patients from England, Scotland, and Wales, 5.8 per cent (4,211) had taken NSAIDs prior to hospital admission between January and August 2020.Further research and clinical trials are needed to establish whether NSAIDs are safe in different populations and whether their anti-inflammatory effects have any impact on patients with Covid-19, the researchers said.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Covaxin , Covishield , Covid-19 Vaccine , COVID-19 Vaccination , COVID Vaccination , Coronavirus Vaccine , Oxygen , #OxygenCylinders , #oxygen , Oxygen Cylinders , SARS-CoV-2 , Health , Study , London , Research , Researchers , World News , Non-steroidal anti-inflammatory drugs , NSAIDs , Ibuprofen

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD